Amended Statement of Changes in Beneficial Ownership (4/a)
May 05 2021 - 3:35PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
EASTHAM KARIN |
2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC.
[
VCYT
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
6000 SHORELINE COURT, SUITE 300 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/25/2021 |
(Street)
SOUTH SAN FRANCISCO, CA 94080
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
2/26/2021 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 2/25/2021 | | M(1) | | 6250 | A | $4 | 6250 | D | |
Common Stock | 2/25/2021 | | S(1) | | 2444 | D | $60.0269 (2) | 3806 | D | |
Common Stock | 2/25/2021 | | S(1) | | 3606 | D | $61.0923 (3) | 200 | D | |
Common Stock | 2/25/2021 | | S(1) | | 200 | D | $61.77 | 0 | D | |
Common Stock | | | | | | | | 13227 | I | By IRA |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (right to buy) | $4.0 | 2/25/2021 | | M (1) | | | 6250 | (4) | 12/5/2022 | Common Stock | 6250.0 | $0 | 0 | D | |
Explanation of Responses: |
(1) | The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 12, 2020. |
(2) | Represents weighted average sales price. Sale prices for the transactions range from $59.57 to $60.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
(3) | Represents weighted average sales price. Sale prices for the transactions range from $60.62 to $61.59. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
(4) | The option is fully vested. |
Remarks: This amendment to Form 4 filed on February 26, 2021 is filed to include the Reporting Person's holdings of 13,227 shares of the Issuer's Common Stock through an individual retirement account, which holdings were inadvertently omitted from such Form 4. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
EASTHAM KARIN 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO, CA 94080 | X |
|
|
|
Signatures
|
/s/ Keith S. Kennedy, as Attorney-in-fact | | 5/5/2021 |
**Signature of Reporting Person | Date |
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Apr 2024 to May 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From May 2023 to May 2024